Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Androgens can help prevent memory problems caused by apoE4.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Finasteride and dutasteride might lower melanoma risk.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Hair loss in women may have causes other than hormones.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

More dermal papilla cells in hair follicles lead to larger, healthier hair, while fewer cells cause hair thinning and loss.